13F Insight
DOSSIER · 13F-HR · Q2 2026

Stonepine Capital Management, LLC

$177M in tracked AUM across 87 positions as of Q2 2026.

SC
CIK 0001440771 · last filed Jun 30, 2026
Total AUM
$177M
as of Q2 2026
Holdings
87
—
positions
Whale Score
60
60
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

Stonepine Capital Management, LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
EOLS
EVOLUS INC
$14M2.0M8.0%02
ADMA
ADMA BIOLOGICS INC
$14M1.4M8.0%03
VSTM
VERASTEM INC
$13M3.3M7.2%04
TENX
TENAX THERAPEUTICS INC
$10M660K5.4%05
NKTR
NEKTAR THERAPEUTICS
$8M121K4.8%06
RARE
ULTRAGENYX PHARMACEUTICAL IN
$6M225K3.6%07
CAMP
CAMP4 THERAPEUTICS CORP
$6M1.4M3.4%08
INSM
INSMED INC
$6M40K3.2%09
ELOX
ELOXX PHARMACEUTICALS INC
$6M397K3.1%10
KZIA
KAZIA THERAPEUTICS LTD
$5M345K2.7%

Filing history

2026Q2Jun 30
$177M▼ 29.0%
87 positionsView →2026Q1Mar 31
$250M▲ 82.3%
83 positionsView →2025Q4Dec 31
$137M▲ 11.4%
66 positionsView →2025Q3Sep 30
$123M▲ 20.7%
58 positionsView →2025Q2Jun 30
$102M▲ 24.9%
59 positionsLocked2025Q1Mar 31
$82M▼ 34.1%
47 positionsLocked2024Q4Dec 31
$124M▼ 21.7%
52 positionsLocked2024Q3Sep 30
$158M▲ 44.4%
38 positionsLocked2024Q2Jun 30
$110M▼ 13.1%
25 positionsLocked2024Q1Mar 31
$126M▼ 45.5%
20 positionsLocked2023Q4Dec 31
$231M▼ 23.2%
16 positionsLocked2023Q3Sep 30
$301M▲ 13.1%
23 positionsLocked
Showing 12 of 42